Annual increment in DMFT (D3) · Children and adolescents with permanent dentition
Not adjusted meta-regression beta was 0.18 per additional follow-up year.
5 findings from 1 review
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Not adjusted
Meta-regression beta per year of follow-up 0.18 [-0.04, 0.40]
13 studies · 24753 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for bitewings and age at baseline
Meta-regression beta per year of follow-up 0.18 [0.02, 0.35]
13 studies · 24753 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for bitewings age at baseline and baseline caries experience
Meta-regression beta per year of follow-up 0.23 [0.06, 0.40]
13 studies · 24753 participants
GRADE not reported
Show 2 more findings
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for groups 1-4 including relevance of evidence and risk of bias
Meta-regression beta per year of follow-up -0.04 [-0.34, 0.26]
13 studies · 24753 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for groups 1-3 including decade and preventive intervention
Meta-regression beta per year of follow-up 0.07 [-0.24, 0.39]
13 studies · 24753 participants
GRADE not reported
Caries incidence rate per person-year at risk (D3) · Children and adolescents with permanent dentition
Adjusted for groups 1-4 including relevance of evidence and risk of bias meta-regression beta was -0.02 per additional follow-up year.
5 findings from 1 review
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for groups 1-4 including relevance of evidence and risk of bias
Meta-regression beta per year of follow-up -0.02 [-0.05, 0.01]
15 studies · 10768 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for bitewings age at baseline and baseline caries experience
Meta-regression beta per year of follow-up 0.00 [-0.00, 0.01]
15 studies · 10768 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for bitewings and age at baseline
Meta-regression beta per year of follow-up 0.00 [-0.00, 0.01]
15 studies · 10768 participants
GRADE not reported
Show 2 more findings
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for groups 1-3 including decade and preventive intervention
Meta-regression beta per year of follow-up -0.00 [-0.02, 0.02]
15 studies · 10768 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Not adjusted
Meta-regression beta per year of follow-up -0.00 [-0.01, 0.01]
15 studies · 10768 participants
GRADE not reported
Intervention not reported
Behavioural outcome: colorectal cancer screening IVR, unidirectional ATCS versus usual care or letter at longer (9‐12 months) · participants at risk for breast, colorectal or cervical cancer; or osteoporosis
The intervention showed no clear difference in behavioural outcome: colorectal cancer screening IVR, unidirectional… (moderate certainty).
1 finding from 1 review
Attention · Breastfeeding mothers
1 finding from 1 review
Visual acuity · Breastfeeding mothers
1 finding from 1 review
Child weight ‐ Long term beyond 24 months · Breastfeeding mothers
1 finding from 1 review
Clinical remission · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical improvement · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maintenance of clinical remission · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
No episodes of acute pouchitis · Patients with ileal pouch‐anal anastomosis
It is very uncertain whether bifidobacterium longum changes no episodes of acute pouchitis compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of herpes labialis during use of the preventative intervention · participants with recurrent herpes labialis
1 finding from 1 review
Adverse effects during use of the preventative intervention · participants with recurrent herpes labialis
Valaciclovir (long‐term) showed no clear difference in adverse effects during use of the preventative intervention compared with placebo (moderate certainty).
1 finding from 1 review
Proportion of participants developing new or progressive SCI lesions · prevention of SCI in people with SCD and normal TCD velocities
Long‐term RBC transfusion showed no clear difference in proportion of participants developing new or progressive SCI lesions compared with standard care (low certainty).
1 finding from 1 review
SCD ‐ related SAEs ‐ ACS · prevention of SCI in people with SCD and abnormal TCD velocities
Long‐term RBC transfusion may leads to lower SCD ‐ related SAEs ‐ ACS compared with standard care (low certainty).
1 finding from 1 review
SCD‐related SAEs ‐ pain crisis · prevention of SCI in people with SCD and abnormal TCD velocities
It is very uncertain whether long‐term RBC transfusion changes SCD‐related SAEs ‐ pain crisis compared with standard care (very low certainty).
1 finding from 1 review
Stroke · prevention of SCI in people with SCD and abnormal TCD velocities
Long‐term RBC transfusion may leads to lower clinical stroke compared with standard care (low certainty).
1 finding from 1 review
Cognitive function ‐ not reported · prevention of SCI in people with SCD and abnormal TCD velocities
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life ‐ not reported · prevention of SCI in people with SCD and abnormal TCD velocities
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · prevention of SCI in people with SCD and normal TCD velocities
1 finding from 1 review